We are a clinical-stage biopharmaceutical company founded to confront the global brain disease crisisby taking a fundamentally different approach to the way treatments for brain diseases are developed. Our principal executive offices are located at 490 Arsenal Way, Suite 200, Watertown, Massachusetts.
